Shenzhen Neptunus Bioengineering Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 19,867.89 million compared to CNY 18,030.52 million a year ago. Revenue was CNY 19,953.81 million compared to CNY 18,121.35 million a year ago.

Net income was CNY 87.68 million compared to CNY 113.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.0319 compared to CNY 0.0414 a year ago. Diluted earnings per share from continuing operations was CNY 0.0319 compared to CNY 0.0414 a year ago.